JP2008526935A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526935A5 JP2008526935A5 JP2007550830A JP2007550830A JP2008526935A5 JP 2008526935 A5 JP2008526935 A5 JP 2008526935A5 JP 2007550830 A JP2007550830 A JP 2007550830A JP 2007550830 A JP2007550830 A JP 2007550830A JP 2008526935 A5 JP2008526935 A5 JP 2008526935A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- drug
- intended
- wound
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 15
- 229940079593 drug Drugs 0.000 claims 14
- 206010052428 Wound Diseases 0.000 claims 10
- 208000027418 Wounds and injury Diseases 0.000 claims 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 231100000241 scar Toxicity 0.000 claims 5
- 125000000539 amino acid group Chemical group 0.000 claims 3
- 230000029663 wound healing Effects 0.000 claims 3
- 208000002847 Surgical Wound Diseases 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 230000035876 healing Effects 0.000 claims 2
- 230000001575 pathological effect Effects 0.000 claims 2
- GTORPNRZTBKYJB-AIEIIIEWSA-N (2s)-4-amino-2-[[(2s)-2-[[(2s,3s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s,3r)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-aminopropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-hydroxybutanoyl]amino]-4-methylsulfanylbutanoyl]amino]hexanoyl Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=C(O)C=C1 GTORPNRZTBKYJB-AIEIIIEWSA-N 0.000 claims 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 206010072170 Skin wound Diseases 0.000 claims 1
- 108010034537 alanyl-tyrosyl-methionyl-threonyl-methionyl-lysyl-isoleucyl-arginyl-asparagine Proteins 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 238000002316 cosmetic surgery Methods 0.000 claims 1
- 230000028709 inflammatory response Effects 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 230000037390 scarring Effects 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0500643.2A GB0500643D0 (en) | 2005-01-13 | 2005-01-13 | Medicaments |
| PCT/GB2006/000051 WO2006075138A2 (en) | 2005-01-13 | 2006-01-06 | Il-10 related peptides for wound healing |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012165481A Division JP2012211185A (ja) | 2005-01-13 | 2012-07-26 | 創傷治癒のためのil−10関連ペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526935A JP2008526935A (ja) | 2008-07-24 |
| JP2008526935A5 true JP2008526935A5 (enExample) | 2009-02-26 |
Family
ID=34224534
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007550830A Pending JP2008526935A (ja) | 2005-01-13 | 2006-01-06 | 創傷治癒のためのil−10関連ペプチド |
| JP2012165481A Pending JP2012211185A (ja) | 2005-01-13 | 2012-07-26 | 創傷治癒のためのil−10関連ペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012165481A Pending JP2012211185A (ja) | 2005-01-13 | 2012-07-26 | 創傷治癒のためのil−10関連ペプチド |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20080139478A1 (enExample) |
| EP (2) | EP1858544B1 (enExample) |
| JP (2) | JP2008526935A (enExample) |
| AU (1) | AU2006205696C1 (enExample) |
| CA (1) | CA2594798A1 (enExample) |
| GB (1) | GB0500643D0 (enExample) |
| WO (1) | WO2006075138A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0500643D0 (en) | 2005-01-13 | 2005-02-23 | Renovo Ltd | Medicaments |
| KR20150072458A (ko) * | 2006-11-15 | 2015-06-29 | 코다 테라퓨틱스, 인크. | 상처 치유를 위한 개선 방법 및 조성물 |
| CA2767132C (en) | 2009-07-06 | 2017-06-20 | Astrazeneca Ab | Intermediates and processes for the preparation of 4-(acetylamino))-3-[(4-chloro-phenyl)thio]-2-methyl-1h-indole-1-acetic acid |
| US20140112898A1 (en) * | 2011-03-31 | 2014-04-24 | President And Fellows Of Harvard College | Unique population of regulatory t cells that regulate tissue regeneration and wound healing |
| KR20160003651A (ko) * | 2013-03-14 | 2016-01-11 | 가부시끼가이샤 쓰리디 매트릭스 | 위장 폐색 예방용 물질 |
| JP2016519108A (ja) | 2013-04-18 | 2016-06-30 | アルモ・バイオサイエンシーズ・インコーポレイテッド | インターロイキン−10を疾病及び疾患の治療に用いる方法 |
| WO2014204816A2 (en) | 2013-06-17 | 2014-12-24 | Armo Biosciences, Inc. | Method for assessing protein identity and stability |
| US10098929B2 (en) | 2013-08-02 | 2018-10-16 | Children's Hospital Medical Center | Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan |
| CA2920679A1 (en) | 2013-08-30 | 2015-03-05 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| CN105848674A (zh) | 2013-11-11 | 2016-08-10 | 阿尔莫生物科技股份有限公司 | 将白细胞介素-10用于治疗疾病和病症的方法 |
| US10293043B2 (en) | 2014-06-02 | 2019-05-21 | Armo Biosciences, Inc. | Methods of lowering serum cholesterol |
| CA2963989A1 (en) | 2014-10-14 | 2016-04-21 | Armo Biosciences, Inc. | Interleukin-15 compositions and uses thereof |
| CN107106655A (zh) | 2014-10-22 | 2017-08-29 | 阿尔莫生物科技股份有限公司 | 使用白细胞介素‑10治疗疾病和病症的方法 |
| WO2016126615A1 (en) | 2015-02-03 | 2016-08-11 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| CN107847583A (zh) | 2015-05-28 | 2018-03-27 | 阿尔莫生物科技股份有限公司 | 用于治疗癌症的聚乙二醇化白细胞介素‑10 |
| EP3341012B1 (en) | 2015-08-25 | 2025-07-30 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6217857B1 (en) * | 1989-06-28 | 2001-04-17 | Schering Corporation | Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof |
| US6159937A (en) * | 1994-07-05 | 2000-12-12 | Steeno Research Group A/S | Immunomodulators |
| GB2304047A (en) | 1995-08-09 | 1997-03-12 | Univ Manchester | Pharmaceutical compositions containing cytokines |
| AU4385696A (en) * | 1996-01-18 | 1997-08-11 | Christian Gronhoj Larsen | Synthetic il-10 analogues |
| GB0500643D0 (en) | 2005-01-13 | 2005-02-23 | Renovo Ltd | Medicaments |
-
2005
- 2005-01-13 GB GBGB0500643.2A patent/GB0500643D0/en not_active Ceased
-
2006
- 2006-01-06 US US11/795,135 patent/US20080139478A1/en not_active Abandoned
- 2006-01-06 CA CA002594798A patent/CA2594798A1/en not_active Abandoned
- 2006-01-06 EP EP06701354.0A patent/EP1858544B1/en not_active Not-in-force
- 2006-01-06 EP EP10182870A patent/EP2332566A1/en not_active Withdrawn
- 2006-01-06 JP JP2007550830A patent/JP2008526935A/ja active Pending
- 2006-01-06 AU AU2006205696A patent/AU2006205696C1/en not_active Ceased
- 2006-01-06 WO PCT/GB2006/000051 patent/WO2006075138A2/en not_active Ceased
-
2011
- 2011-10-07 US US13/317,030 patent/US20120238505A1/en not_active Abandoned
-
2012
- 2012-07-26 JP JP2012165481A patent/JP2012211185A/ja active Pending
-
2014
- 2014-09-16 US US14/487,838 patent/US20150218222A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008526935A5 (enExample) | ||
| AU2002334886B2 (en) | Methods and compositions for treating dermal lesions | |
| RU2008136324A (ru) | Желудочно-кишечный пролиферативный фактор и его применения | |
| US20030185839A1 (en) | Methods and compositions for treating dermal lesions | |
| CN102470163B (zh) | 皮肤外用剂组合物 | |
| AU2002334886A1 (en) | Methods and compositions for treating dermal lesions | |
| ES2389285T3 (es) | Péptidos bioactivos cortos y procedimientos para su uso | |
| US20110160118A1 (en) | Methods and compositions for treating oral and esophageal lesions | |
| JP2005516885A5 (enExample) | ||
| JP2012500847A5 (enExample) | ||
| US7538082B2 (en) | Methods and compositions for treating oral and esophageal lesions | |
| WO1999006440A8 (en) | Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome | |
| BR9607336A (pt) | Composições de aminoácidos e utilidades das mesmas em nutrição clinica | |
| TWI305778B (en) | Peptides of an expressing unit for igf-i minimal activity and their pharmaceutical use | |
| WO2003018049A3 (en) | Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection | |
| NO20062198L (no) | Bradykinin B1 reseptorantagonister | |
| WO2024169972A1 (en) | New multi-functional oligopeptides | |
| Bilic et al. | The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in mice | |
| WO2008113970A3 (en) | Peptides | |
| JP2004538320A5 (enExample) | ||
| RU2011133224A (ru) | Новые фармацевтические композиции | |
| CA2423004A1 (en) | Peptide inhibitors of hiv entry | |
| EP2205270A1 (en) | Peptides based on the sequence of human lactoferrin and their use | |
| EP2212352A1 (en) | New synthetic arginine substituted peptides and their use | |
| US8614187B2 (en) | Peptides, compositions and uses thereof |